Bibliography
Export 132 results:
Filters: Keyword is Child, Preschool [Clear All Filters]
Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry. Haematologica. 2008;93(5):735-40.
Prevalence of incidental prostate cancer in the general population: a study of healthy organ donors. J Urol. 2008;179(3):892-5; - discussion - 895.
The use of donor and recipient screening for toxoplasma in the era of universal trimethoprim sulfamethoxazole prophylaxis. Transplantation. 2008;85(7):980-5.
Bacterial keratitis after penetrating keratoplasty: incidence, microbiological profile, graft survival, and visual outcome. Ophthalmology. 2007;114(6):1073-9.
Epstein-Barr virus infection as a complication of transplantation of a nerve allograft from a living related donor. Case report. J Neurosurg. 2007;106(5):924-8.
Infections and human tissue transplants: review of FDA MedWatch reports 2001-2004. Cell Tissue Bank. 2007;8(3):211-9.
Evidence of donor-derived hematologic malignancies after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2006;12(5):511-7.
Heart transplantation across antibodies against human leukocyte antigen and ABO-post-transplant follow-up of donor reactive antibodies. Xenotransplantation. 2006;13(2):101-4.
Chagas disease in bone marrow transplantation: an approach to preemptive therapy. Bone Marrow Transplant. 2005;36(2):123-129.
Safety and efficacy of allogeneic PBSC collection in normal pediatric donors: the pediatric blood and marrow transplant consortium experience (PBMTC) 1996-2003. Bone Marrow Transplant. 2005;35(4):361-7.
Early postoperative complications in recipients of living donor liver transplantation. Transplant Proc. 2004;36(8):2338-41.
Heart transplantation using donors positive for hepatitis. TransplantProc. 2004;36(8):1.
Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type matters. Blood. 2004;103(12):4674-80.
Recurrence risk after organ transplantation in patients with a history of Hodgkin disease or non-Hodgkin lymphoma. Transplantation. 2004;78(7):972-7.
Aggressive pharmacologic donor management results in more transplanted organs. Transplantation. 2003;75(4):482-7.
Donor-cell myelodysplastic syndrome developing 13 years after marrow grafting for aplastic anemia. Cancer Genet Cytogenet. 2003;142(2):124-8.
Factors predicting peripheral blood progenitor cell collection from pediatric donors for allogeneic transplantation. Haematologica. 2003;88(8):919-22.
A multiorgan donor cancer screening protocol: the Italian Emilia-Romagna region experience. Transplantation. 2003;76(12):1695-9.
Anesthetic-related cardiac arrest and its mortality: a report covering 72,959 anesthetics over 10 years from a US teaching hospital. Anesthesiology. 2002;97(1):108-15.
De novo sarcomas in solid organ transplant recipients. Transplant Proc. 2002;34(5):1786-7.
Adverse events in peripheral progenitor cell collection: a 7-year experience. J Hematother Stem Cell Res. 2001;10(5):675-80.
De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population. Liver Transpl. 2001;7(1):1.
The dengue and dengue hemorrhagic fever epidemic in Puerto Rico, 1994-1995. The American journal of tropical medicine and hygiene//Am J Trop Med Hyg. 2001;64(1-2):67-74.
Fatal and non fatal cardiac arrests related to anesthesia. Can J Anaesth. 2001;48(4):326-32.